These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16400393)

  • 1. [Ezetimibe--pharmacokinetics and therapeutics].
    Araújo RG; Casella Filho A; Chagas AC
    Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():20-4. PubMed ID: 16400393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The place of ezetimibe in clinical practice.
    Weston C
    Hosp Med; 2003 Aug; 64(8):473-8. PubMed ID: 12958759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic interaction between ezetimibe and rosuvastatin.
    Kosoglou T; Statkevich P; Yang B; Suresh R; Zhu Y; Boutros T; Maxwell SE; Tiessen R; Cutler DL
    Curr Med Res Opin; 2004 Aug; 20(8):1185-95. PubMed ID: 15324521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor.
    Jeu L; Cheng JW
    Clin Ther; 2003 Sep; 25(9):2352-87. PubMed ID: 14604738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials.
    Sweeney ME; Johnson RR
    Expert Opin Drug Metab Toxicol; 2007 Jun; 3(3):441-50. PubMed ID: 17539750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezetimibe: a selective cholesterol absorption inhibitor.
    Nutescu EA; Shapiro NL
    Pharmacotherapy; 2003 Nov; 23(11):1463-74. PubMed ID: 14620392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy in cholesterol reduction: focus on ezetimibe and statins.
    Grigore L; Norata GD; Catapano AL
    Vasc Health Risk Manag; 2008; 4(2):267-78. PubMed ID: 18561502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ezetimibe--intestinal cholesterol absorbtion inhibitor].
    Pikto-Pietkiewicz W; Pasierski T
    Kardiol Pol; 2006 Dec; 64(12):1434-41. PubMed ID: 17206545
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy and clinical trials: ezetimibe.
    Jialal I; Kappagoda T
    Curr Opin Lipidol; 2003 Dec; 14(6):643-6. PubMed ID: 14624143
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical efficacy of ezetimibe and combined use with statins].
    Pascual Izuel JM; Rodilla Sala E; Sánchez Juan C
    Rev Clin Esp; 2005 Oct; 205(10):496-8. PubMed ID: 16238961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical use of ezetimibe.
    Cheng AY; Leiter LA
    Can J Clin Pharmacol; 2003; 10 Suppl A():21A-5A. PubMed ID: 14571302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zetia (ezetimibe).
    Kloner RA
    Congest Heart Fail; 2003; 9(2):109-10. PubMed ID: 12671344
    [No Abstract]   [Full Text] [Related]  

  • 16. An investigative look: selective cholesterol absorption inhibitors--embarking on a new standard of care.
    Stein EA
    Am J Manag Care; 2002 Feb; 8(2 Suppl):S36-9; discussion S45-7. PubMed ID: 11855701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia.
    Almutairi F; Peterson TC; Molinari M; Walsh MJ; Alwayn I; Peltekian KM
    Liver Transpl; 2009 May; 15(5):504-8. PubMed ID: 19399742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezetimibe.
    Darkes MJ; Poole RM; Goa KL
    Am J Cardiovasc Drugs; 2003; 3(1):67-76; discussion 77-8. PubMed ID: 14727947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
    Geiss HC; Otto C; Parhofer KG
    Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Getting there: statin plus ezetimibe for low-density lipoprotein cholesterol goals.
    Hurley DL; Isley WL
    Mayo Clin Proc; 2005 May; 80(5):585-6. PubMed ID: 15887424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.